Welcome to Hepatitis Delta Connect!
A dedicated program of the Hepatitis B Foundation to increase awareness about hepatitis delta - a serious virus that coinfects hepatitis B patients - and to promote screening and testing, and provide information and support for those affected.
Check out our latest webinar!
Check out our summer 2025 Hepatitis Delta Connect webinar! For this event, we were joined by Dr. Thomas Vanwolleghem, who presented on some of his extensive research about the long-term health outcomes of hepatitis delta, based on studies he has conducted in multiple settings and in a global context. Dr. Vanwolleghem also shared about his work with the Hepatitis Delta International Network and spoke to the urgent need to advocate for improved education about HDV infection and increased access to approved treatments. Please email beatrice.zovich@hepb.org for access to the recording!
New Podcast! Silent Epidemic: Unveiling the Challenges of Hepatitis B & Delta
Check out this podcast episode from Elma Research, in which the conversation explores the ongoing efforts to address hepatitis B and D with Beatrice Zovich from the Hepatitis B Foundation. In this conversation, we look at challenges in diagnosis, the stigma many patients face, and the Foundation’s work to increase awareness and improve policy. Whether you're a healthcare provider, a patient, or simply interested in public health, we hope you'll find this discussion insightful.
Listen here!
Recently Published Paper Calls for Reclassification of Hepatitis Delta as an Orphan Disease
Check Out A New Position Statement on Standardized Surveillance for Hepatitis D Virus Infections
This position statement proposes a standardized surveillance case definition for hepatitis D virus (HDV) infections, commonly known as hepatitis D. Establishing a standardized definition is important because HDV is currently a reportable disease in only 31 jurisdictions of the United States (meaning that, once an individual tests positive for hepatitis delta, this must be reported to the CDC, which would help greatly with surveillance of the disease). The case ascertainment process will rely on clinical and laboratory reports, with case classifications divided into confirmed and probable. This framework aims to improve the accuracy and comparability of HDV surveillance efforts.
Read here.
Get Connected
New YouTube Video! What happens if HDV infection is not treated?
Check out this YouTube video featuring Dr. Heiner Wedemeyer, Director of the Clinic for Gastroenterology, Hepatology, Infectiology and Endocrinology at Hannover Medical School in Germany, as he explains the symptoms and consequences of an untreated HDV infection.
This video is part of the Insights on HDV and HBV series, which is an informative resource designed to equip the community with the essential knowledge to understand the risk of hepatitis D in the context of the hepatitis B virus.
Watch the video here!
In another video from the series, Heleine Kefalakes, a specialist in internal medicine at the Department for Gastroenterology, Hepatology, Infectiology and Endocrinology at the Hannover Medical School in Germany gives a lecture titled “Standard of treatment in Germany and worldwide”
Watch the video here!
Sign up for our Patient and Provider Newsletters
We would love to hear from you! Complete the survey to sign up! Please note: This survey link is specifically for those living with hepatitis delta, or those who are caretakers of people living with hepatitis delta.
Take our brief survey & sign up to receive updates on clinical trials, info about hepatitis delta monitoring, management & care + more! Sign up today! Please note: This survey link is specifically for healthcare providers caring for people living with hepatitis delta.
New Clinical Practice Guidelines from the European Association for the Study of the Liver (EASL)
EASL has published hepatitis delta clinical guidelines with recommendations for testing and surveillance. Read the new guidelines here!
